Hemostatic profile of women using low-dose oral contraceptive Mercilon. (Preliminary report)
Uchikova, E.; Malinova, M.; Pekhlivanov, B.; Ledzhev, I.
Akusherstvo i Ginekologiia 41(3): 23-25
2002
ISSN/ISBN: 0324-0959 PMID: 12145973 Document Number: 377360
The authors have investigated the hemostatic profile at 20 women using low-dosed oral contraceptive Mercilon (Organon) in continuation of six months. Statistically significant changes are found for factor X of hemocoagulation, plasminogen, protein C, protein S and antithrombin III. It is concluded that Mercilon causes activation of the coagulation system, which is balanced by the activation of the fibrinolytic system.
Document emailed within 1 workday
Related Documents
Bakas, P.; Hassiakos, D.; Grigoriadis, C.; Vlahos, N.F.; Liapis, A.; Creatsas, G. 2014: Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(11): 825-829Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
O'Connell, K.J.; Osborne, L.M.; Westhoff, C. 2005: Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive Contraception 72(5): 323-327
Szlendak-Sauer, K.; Radowicki, S.ła.; Skórzewska, K. 2009: The impact of a new low dose oral contraceptive containing drospirenone on lipid profile, carbohydrate metabolism and hepatic function Ginekologia Polska 80(2): 99-102
Nakajima, S.T.; Pappadakis, J.; Archer, D.F. 2016: Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive Contraception 93(1): 52-57
Naz, F.; Jyoti, S.; Akhtar, N.; Afzal, M.; Siddique, Y.H. 2012: Lipid profile of women using oral contraceptive pills Pakistan Journal of Biological Sciences: Pjbs 15(19): 947-950
Ishak, R.; Ahmad, R.; Gudum, H.R.; Hassan, K.; Ang, E.S. 1992: Fibrinolytic response in women on low-dose oral contraceptive Malaysian Journal of Reproductive Health: a Publication of the Reproductive Research Centre of the National Population and Family Development Board Malaysia 10(1): 7-11
Kim, K.; Park, H. 2012: Effect of oral contraceptive use on lipid profile in Korean women aged 35-55 years Contraception 86(5): 500-505
Weisberg, E.; Merki-Feld, G.S.; McGeechan, K.; Fraser, I.S. 2015: Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen Contraception 91(2): 121-126
Li, Y.; Gao, E.; Liu, Y.; Luo, L.; Wang, X.; Wang, H.; Wu, Y.; Zhou, L.; Sun, Z.; Zhang, L.; Wu, S.; Shia, J.; Macaluso, M.; McCarthy, B. 2002: Association between low-dose oral contraceptive use and stroke in Chinese women Zhonghua Yi Xue Za Zhi 82(15): 1013-1017
Koetsawang, S.; Srisupandit, S.; Srivanaboon, S.; Bhiraleus, P.; Rajawatana, D.; Kiriwat, O. 1975: Use of a low-dose oral contraceptive preparation: report of a study Modern Medicine of Asia 11(10): 8-11
Woutersz, T.B. 1981: A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles Journal of Reproductive Medicine 26(12): 615-620
Murphy, A.; Cropp, C.S.; Smith, B.S.; Burkman, R.T.; Zacur, H.A. 1990: Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women Fertility and Sterility 53(1): 35-39
Joffe, H.; Petrillo, L.F.; Viguera, A.C.; Gottshcall, H.; Soares, C.N.; Hall, J.E.; Cohen, L.S. 2007: Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report Journal of Clinical Psychiatry 68(12): 1954-1962
Anzai, Y.; Heger-Mahn, D.; Schellschmidt, I.; Marr, J. 2012: Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women Contraception 86(1): 28-34
Piérard-Franchimont, C.; Gaspard, U.; Lacante, P.; Rhoa, M.; Slachmuylders, P.; Piérard, G.E. 2000: A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 5(4): 275-286
Banaszewska, B.; Spaczyński, R.Z.; Ozegowska, K.; Pawelczyk, L. 2011: The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome Ginekologia Polska 82(6): 430-435
Scholes, D.; Hubbard, R.A.; Ichikawa, L.E.; LaCroix, A.Z.; Spangler, L.; Beasley, J.M.; Reed, S.; Ott, S.M. 2011: Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation Journal of Clinical Endocrinology and Metabolism 96(9): E1380-E1387
Kalbag, J.; Elder, C.; Scott, G.; Wang, Y.; Milosavljev, S.; Leese, P.; Caldwell, J.; Rordorf, C. 2004: Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile Journal of Clinical Pharmacology 44(6): 646-654
Giribela, C.Rosa.Galvão.; Consolim-Colombo, F.Marciano.; Nisenbaum, M.Gil.; Moraes, T.Lemos.de.; Giribela, A.Helena.Galvão.; Baracat, E.Chada.; Melo, N.Roberto.de. 2015: Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(11): 912-915